Nucleic Acid Purification System Suitable for Clinical Labs
By LabMedica International staff writers Posted on 15 Aug 2012 |
An in vitro diagnostic (IVD) system purifies nucleic acids from up to 96 clinical samples in less than 60 minutes.
Called MagNA Pure 96, the CE certified system was launched by Roche (Penzberg, Germany) for automated sample preparation. The system was designed to be suitable for use in clinical laboratories for diagnostic purposes. The IVD version of MagNA Pure 96 has already been introduced in the US.
The MagNA Pure 96 System provides ready-to-use reagents and uses a minimal number of consumables. It can purify nucleic acids from a wide spectrum of human samples. The system provides laboratory information management system (LIMS) connectivity for safe and convenient data transfer. This ensures data integrity and avoids redundant data handling
The MagNA Pure 96 System purifies DNA, RNA, and viral nucleic acids from a wide variety of starting materials using the magnetic glass particle technology developed by Roche. Preprogrammed software protocols are tailored to sample requirements and yield high-purity nucleic acids that are ideal for a broad range of downstream applications.
Hands-on time is reduced by using bar-coded prefilled reagent trays with ready-to-use reagents, disposables, intuitive software, and optimized preprogrammed purification protocols.
Related Links:
Roche
Called MagNA Pure 96, the CE certified system was launched by Roche (Penzberg, Germany) for automated sample preparation. The system was designed to be suitable for use in clinical laboratories for diagnostic purposes. The IVD version of MagNA Pure 96 has already been introduced in the US.
The MagNA Pure 96 System provides ready-to-use reagents and uses a minimal number of consumables. It can purify nucleic acids from a wide spectrum of human samples. The system provides laboratory information management system (LIMS) connectivity for safe and convenient data transfer. This ensures data integrity and avoids redundant data handling
The MagNA Pure 96 System purifies DNA, RNA, and viral nucleic acids from a wide variety of starting materials using the magnetic glass particle technology developed by Roche. Preprogrammed software protocols are tailored to sample requirements and yield high-purity nucleic acids that are ideal for a broad range of downstream applications.
Hands-on time is reduced by using bar-coded prefilled reagent trays with ready-to-use reagents, disposables, intuitive software, and optimized preprogrammed purification protocols.
Related Links:
Roche
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability